OR Royalties Inc. (NYSE:OR) Receives $40.50 Consensus Target Price from Analysts

OR Royalties Inc. (NYSE:OR) has been given an average recommendation of “Hold” by the nine analysts that are currently covering the company, Marketbeat reports. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, three have given a buy rating and one has given a strong buy rating to the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $40.50.

A number of brokerages have recently weighed in on OR. Scotiabank lowered their price target on OR Royalties from $51.00 to $42.00 and set a “sector perform” rating on the stock in a report on Tuesday, July 14th. Wall Street Zen downgraded OR Royalties from a “buy” rating to a “hold” rating in a research note on Saturday, June 6th. Jefferies Financial Group decreased their price objective on OR Royalties from $40.00 to $34.00 and set a “hold” rating for the company in a research report on Monday, July 6th. Zacks Research cut OR Royalties from a “hold” rating to a “strong sell” rating in a research note on Monday, July 13th. Finally, Royal Bank Of Canada dropped their target price on OR Royalties from $50.00 to $45.00 and set an “outperform” rating on the stock in a report on Thursday, July 9th.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in OR. State of Wyoming purchased a new stake in OR Royalties in the 1st quarter worth approximately $28,000. FIL Ltd purchased a new position in shares of OR Royalties during the 4th quarter valued at $29,000. Banque Cantonale Vaudoise purchased a new position in shares of OR Royalties during the 1st quarter valued at $37,000. Grove Bank & Trust acquired a new position in shares of OR Royalties in the second quarter worth $32,000. Finally, Assetmark Inc. acquired a new position in shares of OR Royalties in the fourth quarter worth $36,000. Institutional investors and hedge funds own 68.52% of the company’s stock.

OR Royalties Stock Up 2.2%

Shares of OR opened at $36.07 on Thursday. OR Royalties has a fifty-two week low of $27.54 and a fifty-two week high of $48.06. The company has a quick ratio of 2.28, a current ratio of 2.28 and a debt-to-equity ratio of 0.14. The firm has a market cap of $6.72 billion, a PE ratio of 24.05 and a beta of 0.75. The company’s fifty day moving average is $31.63 and its two-hundred day moving average is $36.54.

OR Royalties (NYSE:OR) last released its earnings results on Wednesday, August 5th. The basic materials company reported $0.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.31 by $0.01. The company had revenue of $97.82 million during the quarter, compared to analyst estimates of $97.93 million. OR Royalties had a return on equity of 16.41% and a net margin of 78.04%. Analysts forecast that OR Royalties will post 1.25 earnings per share for the current year.

OR Royalties Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Wednesday, September 30th will be given a dividend of $0.065 per share. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $0.26 dividend on an annualized basis and a yield of 0.7%. OR Royalties’s payout ratio is presently 16.67%.

About OR Royalties

OR Royalties PLC (NYSE: OR) is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes.

The company’s core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets.